$NUTX Cashflow Statement | Understand Stock

$NUTX

$208.25 -$0.75 (0.36%) Close

$NUTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
(Income) loss from discontinued operations
Net loss from continuing operations
Net income (loss)
Adjustment to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization
Interest expense associated with debt discount
Non cash interest expense
Purchase price adjustment to investment in AHP
Settlement payment from ACMG
Income from forgiveness of debt
Amortization of debt issuance costs
Impairment of assets
Impairment of goodwill
Gain on sale of assets
Impairment of investment
Derecognition of goodwill
Loss on warrant liability
Stock-based compensation expense
Rescission of warrant exercise expense
Other income - gain on PPP loan forgiveness
Changes to deferred taxes
Debt accretion expense
Loss on lease termination
Loss on sale of assets
Cancellation of common stock
Loss on extinguishment of debt
Non-cash lease expense
Changes in operating assets and liabilities:
(Increase)/Decrease in Accounts receivable
Nonrelated Party
Related Party
Total (Increase)/Decrease in Accounts receivable
Accounts receivable - related party
(Increase)/Decrease in Inventories
(Increase)/Decrease in Prepaid expenses and other current assets
Deposits and other assets
Accounts payable and accrued expenses
Customer deposits
Accrued interest on notes payable
Lease liability
Deferred revenue
Accounts payable
Accounts payable - related party
(Increase)/Decrease in Operating right-of-use assets
Increase/(Decrease) in Accounts payable
Nonrelated Party
Related Party
Increase/(Decrease) in Operating lease liabilities
Increase/(Decrease) in Accrued arbitration expenses
Increase/(Decrease) in Accrued income tax expense
Increase/(Decrease) in Accrued expenses and other current liabilities

Net cash provided by operating activities

Cash flows from investing activities:
Proceeds from sale of investment in ACMG
Distribution from investment in ACMG
(Increase) decrease in restricted cash
Sale of property and equipment
Payment to AHP shareholder for litigation settlement
Preacquisition loans from subsidiary
Cash acquired from acquisitions
Net cash provided by in continuing investing activities
Net cash used in discontinued investing activities
Acquired cash in reverse acquisition with Clinigence
Acquisitions of property and equipment
Purchase of restricted short-term investment
Cash related to sale of business
Proceeds from restricted short-term investment
Payments for acquisitions of businesses, net of cash acquired
Cash related to asset acquisition
Cash related to deconsolidation of Real Estate Entities
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from sale of common stock
Proceeds from lines of credit
Proceeds from notes payable
Proceeds from convertible notes
Repayments of lines of credit
Repayments of notes payable
Payments of financing costs for capital raise
Proceeds from related party loans
Payments on notes and convertible notes payable
Payment of debt issuance costs
Recission of warrant exercise
Repayments of finance leases
Proceeds from common stock issuance, net issuance costs
Rescission of warrant exercise
Proceeds from exercise of warrants
Proceeds from exercise of options
Cash related to stock repurchases and retirements
Members' contributions
Members' distributions
Net cash provided by (used in) financing activities

Net change in cash and cash equivalents
Cash and cash equivalents - beginning of the year
Cash and cash equivalents - end of the year
Cash and cash equivalents - beginning of the period
Restricted cash - beginning of period
Cash and cash equivalents and restricted cash - beginning of period
Cash and cash equivalents - end of period
Restricted cash - end of period
Cash and cash equivalents and restricted cash - end of period
Interest
Sale of software in consideration of Series E preferred stock, convertible notes and other liabilities assumed
Common stock issued for acquisition of subsidiaries
Common stock issued for subscriptions receivable
Purchase price adjustment to investment in AHA
Related party loans converted to common stock
Notes payable converted to accounts payable
Notes payable converted to common stock
Accrued interest converted to convertible notes payable
Deferred tax liability recorded on intangible assets
Debt discount on notes payable
Right of use asset added for operating lease

Comments